Clinical trials: Recurrent Bacterial Vaginosis (BV)

Bacterial Vaginosis

Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)

• Completed
• Age: 16 to 45 years
• Phase 3
• Pill or oral medicine
• Results posted

A double-blind, phase 3 study to determine the efficacy of SPL7013 Gel when administered on alternate days for 16 weeks, compared to placebo gel in preventing the recurrence of BV in women with a history of recurrent BV.

Trial name

NCT02237950

Testing

Metronidazole oral tablets 500mg, 1% SPL7013 Gel

Where

45 sites in United States, Canada and 1 more

Volunteers

586 people

Sponsor

Starpharma Pty Ltd